VAERS reports by lot

Pfizer Pneumococcal lot FJ2603: VAERS reports

48 VAERS reports list lot FJ2603 as a Pfizer Pneumococcal vaccine, received between 2022-03-07 and 2023-05-01. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
48
Reports
0%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction10149%
General / Systemic (non-local)2914%
Musculoskeletal2110%
Dermatological (non-injection-site)178%
Neurological157%
Cardiac / Cardiovascular63%
Allergic / Anaphylactic52%
Respiratory52%
Gastrointestinal52%
Psychiatric / Neuropsychiatric10%

Where reports came from

U.S. state of the reporter, where given (top 12).

North Carolina6
Texas4
California3
Michigan3
New York3
South Carolina3
Georgia3
Pennsylvania2
Illinois2
Kansas1
Ohio1
Washington1

Reports by month received

2022-038
2022-048
2022-053
2022-063
2022-076
2022-087
2022-093
2022-101
2022-114
2023-011
2023-031
2023-042
2023-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.